RalphSalloumMD
Pediatric Hematology & Oncology • Boston, MAPediatric Neuro-Oncology
Associate Professor of Clinical Pediatrics
Dr. Salloum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3000Fax+1 614-722-8826
Summary
- Dr. Ralph Salloum is a pediatric hematologist/oncologist in Columbus, OH and is affiliated with Nationwide Children's Hospital. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 11 years. He also speaks multiple languages, including Arabic, French, and Spanish. He specializes in pediatric neuro-oncology and is experienced in investigational drugs. He has more than 30 publications and over 300 citings.
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Neuro-Oncology, 2014 - 2015- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine/Pediatrics, 2007 - 2011
American University of Beirut Faculty of MedicineClass of 2006
Certifications & Licensure
OH State Medical License 2011 - 2026
MA State Medical License 2024 - 2025
MI State Medical License 2007 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors Start of enrollment: 2018 Nov 27
- Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery Start of enrollment: 2019 Jul 25
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors Start of enrollment: 2022 Nov 21
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsPatterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosisRalph Salloum, Mariko DeWire, Adam Lane, Stewart Goldman, Trent R. Hummel
Journal of Neuro-Oncology. 2015-02-01 - 16 citationsImpact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents.Allison P. Fisher, Jamie Patronick, Cynthia A. Gerhardt, Krestin Radonovich, Ralph Salloum
Pediatric Blood & Cancer. 2021-05-24 - 13 citationsA Survivor's Journey: Preliminary efficacy of an online problem-solving therapy for survivors of pediatric brain tumor.Shari L. Wade, Megan E. Narad, Emily L. Moscato, Elizabeth LeBlond, Jessica A. King
Pediatric Blood & Cancer. 2020-02-01
Press Mentions
Late Morbidity and Mortality in Survivors of MedulloblastomaMarch 6th, 2019
Other Languages
- Arabic, French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
